Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Regulation of microRNA expression and abundance during lymphopoiesis.

Kuchen S, Resch W, Yamane A, Kuo N, Li Z, Chakraborty T, Wei L, Laurence A, Yasuda T, Peng S, Hu-Li J, Lu K, Dubois W, Kitamura Y, Charles N, Sun HW, Muljo S, Schwartzberg PL, Paul WE, O'Shea J, Rajewsky K, Casellas R.

Immunity. 2010 Jun 25;32(6):828-39. doi: 10.1016/j.immuni.2010.05.009.

2.

Epigenetic architecture and miRNA: reciprocal regulators.

Wiklund ED, Kjems J, Clark SJ.

Epigenomics. 2010 Dec;2(6):823-40. doi: 10.2217/epi.10.51. Review.

PMID:
22122085
3.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Review.

PMID:
23246696
4.

MicroRNAs grow up in the immune system.

Hoefig KP, Heissmeyer V.

Curr Opin Immunol. 2008 Jun;20(3):281-7. doi: 10.1016/j.coi.2008.05.005. Review.

PMID:
18554884
5.

MiRNAs, epigenetics, and cancer.

Rouhi A, Mager DL, Humphries RK, Kuchenbauer F.

Mamm Genome. 2008 Aug;19(7-8):517-25. doi: 10.1007/s00335-008-9133-x. Review.

PMID:
18688563
6.

Regulation of microRNA biogenesis and function.

Treiber T, Treiber N, Meister G.

Thromb Haemost. 2012 Apr;107(4):605-10. doi: 10.1160/TH11-12-0836. Review.

PMID:
22318703
7.

Mechanisms of microRNA deregulation in human cancer.

Deng S, Calin GA, Croce CM, Coukos G, Zhang L.

Cell Cycle. 2008 Sep 1;7(17):2643-6. Review.

PMID:
18719391
8.

MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine.

Mishra PJ, Bertino JR.

Pharmacogenomics. 2009 Mar;10(3):399-416. doi: 10.2217/14622416.10.3.399. Review.

9.

MicroRNA biogenesis: Epigenetic modifications as another layer of complexity in the microRNA expression regulation.

Bhat SS, Jarmolowski A, Szweykowska-KuliƄska Z.

Acta Biochim Pol. 2016;63(4):717-723. Review.

10.

MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Yu AM, Tian Y, Tu MJ, Ho PY, Jilek JL.

Drug Metab Dispos. 2016 Mar;44(3):308-19. doi: 10.1124/dmd.115.067470. Review.

PMID:
26566807
Items per page

Supplemental Content

Support Center